Systematic screening of chromosome 18 for loss of heterozygosity in esophageal squamous cell carcinoma

Cancer Genetics and Cytogenetics

Volumn 111, Issue 1, 1999, Pages 81-86

  Karkera, Jayaprakash D ^a,b   Balan, Kannan V ^c   Yoshikawa, Takeo ^b   Lipman, Timothy O ^a   Korman, Louis ^a   Sharma, Aparna ^a   Patterson, Robert H ^a,d   Sani, Nirmal ^a,d   Detera Wadleigh, Sevilla D ^b   Wadleigh, Robert G ^a  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b Unit of Gene Mapping and Expression   (United States)

^c HOWARD UNIVERSITY   (United States)

^d GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 18P; CHROMOSOME 18Q; CHROMOSOME ANALYSIS; CHROMOSOME FRAGILE SITE; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; GENETIC SCREENING; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0032930062     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00225-8     Document Type: Article

References (34)

1. Parkin D.M., Pisani P., Ferlay J. Estimates of the worldwide incidence of 18 major cancers in 1985. Int J Cancer. 54:1993;594-606.
2. Pisani P., Parkin D.M., Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Int J Cancer. 55:1993;891-903.
3. Kosary CL, Ries LAG, Miller BA, Hankey BF, Harras A, Edwards BK (eds) (1996): Surveillance, Epidemiology, and End Results (SEER) Review, (1973-1994). National Cancer Institute.
4. Gao Y.T., McLaughlin J.K., Blot W.J., Ji B.T., Benichou J., Dai Q., Fraumeni J.F. Risk factors for esophageal cancer in Shangai China. I. Role of cigarette smoking and alcohol drinking Int J Cancer. 58:1994;192-196.
5. Ashan H., Neugut A.I., Gammon M.D. Association of adenocarcinoma and squamous cell carcinoma of the esophagus with tobacco-related and other malignancies. Cancer Epidemiol Biomarkers Prev. 6:1997;779-782.
6. Montesano R., Hollstein M., Hainut P. Genetic alteration in esophageal cancer and their relevance to etiology and pathogenesis. a review Int J Cancer. 69:1996;225-235.
7. Metlzer S.J. The molecular biology of esophageal carcinoma. Cancer Res. 142:1996;1-8.
8. Fearon E.R., Cho K.R., Nigro J.M., Kern S.E., Simons J.W., Ruppert J.M., Hamilton S.R., Presinger A.C., Thomas G., Kinzler K.W., Vogelstein B. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science. 247:1990;49-56.
9. Hahn S.A., Schutte M., Shamsul-Hoque A.T.M., Moskaluk C.A., da Costa L.T., Rozenblum E., Weistein C.L., Fischer A., Yeo C.J., Hruban R.H., Kern S.E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 271:1996;350-353.
10. Shibagaki I., Shimada Y., Wagatta T., Ikenaga M., Imamura M., Ishizaki K. Alleotype analysis of esophageal squamous cell carcinoma. Cancer Res. 54:1994;2996-3000.
11. Lei J., Zou T., Shi Y., Zhou X., Smolinksi K.N., Yin J., Souza R.F., Appel R., Wang S., Cymes K., Chan O., Abraham J.M., Harpaz N., Meltzer S.J. Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms. Oncogene. 13:1996;2459-2462.
12. Barrett M.T., Schutte M., Kern S.E., Reid B.J. Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res. 56:1996;4351-4353.
13. Aoki T., Mori T., XiQun D., Nishira T., Matsubara T., Nakamura Y. Allelotype study of esophageal carcinoma. Genes Chromosom Cancer. 10:1994;177-182.
14. Goelz S.E., Hamilton S.R., Vogelstein B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun. 130:1985;118-126.
15. Dib C., Faure S., Fizames S., Samson D., Drouot N., Vignal A., Millasseau P., Marc S., Hazan J., Seboun E., Lathrop M., Gyapay G., Morissette J., Weissenbach J. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature. 380:1996;152-154.
16. Collins A., Frezal J., Teague J., Morton N.E. A metric map of humans. 23,500 loci in 850 bands Proc Natl Acad Sci USA. 93:1996;14771-14775.
17. Eppert K., Scherer S.W., Ozcelik H., Pirone R., Hoodless P., Kim H., Tsui L.-C., Bapat B., Gallinger S., Andrulis I.L., Thomsen G.H., Wrana L., Attisano L. MADR2 maps to 18q21 and encodes a TGF-β-regulated MAD related protein that is functionally mutated in colorectal carcinoma. Cell. 86:1996;543-552.
18. Riggins G.J., Thiagalingam S., Rozenblum E., Weinstein C., Kern S.E., Hamilton S.R., Wilson J.K.V., Markowitz S.D., Kinzler K.W., Vogelstein B. Mad-related genes in the human. Nature Genet. 13:1996;347-349.
19. Cho K.R., Oliner J.D., Simons J.W., Hedrick L., Fearon E.R., Preisinger A.C., Hedge P., Silverman G.A., Vogelstein B. The DCC gene. Structural analysis and mutations in colorectal carcinomas Genomics. 19:1994;525-531.
20. Cox D.R., Burmeister M., Price E.R., Kim S., Myers R.M. Radiation hybrid mapping. A somatic cell genetic method for constructing high resolution maps of mammalian chromosomes Science. 250:1990;245-250.
21. Jones J.W., Raval J.R., Beals T.F., Worsham M.J., VanDyke D.L., Esclamado R.M. Frequent loss of heterozygosity on chromosome 18q in squamous cell carcinomas. Identification of 2 regions of loss - 18q11.1-q12.3 and 18q21.1-q23. Arch Otolaryngol Head Neck Surg. 123:1997;610-614.
22. Hecht F., Ramesh K.H., Lockwood D.H. A guide to fragile sites on human chromosomes. Cancer Genet Cytogenet. 44:1990;37-45.
23. Popescu N.C. Chromosome fragility and instability in human cancer. Critical Rev in Oncol. 5:1994;121-140.
24. Daly M.C., Douglas J.B., Bleeham N.M., Hasleton P., Twentyman P.R., Sunderason V., Carritt B., Bergh J., Rabbits P.H. An unusually proximal deletion on the short arm of human chromosome 3 in a patient with small cell lung cancer. Genomics. 9:1991;113-119.
25. Yokoyama S., Yamakawa K., Tsuchiya E., Murata M., Sakiyama S., Nakamura Y. Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res. 52:1993;973-977.
26. Kovacs G., Erlandsson R., Boldog F., Ingvarsson S., Muller-Brechlin R., Klein G., Sumegi J. Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci USA. 85:1988;1571-1575.
27. Pandis N., Yin Y.S., Limon J., Bardi G., Idvall I., Mendahl N., Mittelman F., Heim S. Interstitial deletion of the short arm of chromosome 3 as primary chromosome abnormality in carcinomas of the breast. Genes Chromosom Cancer. 6:1993;151-155.
28. Shridhar R., Shridhar V., Wang X., Pardee W., Dugan M., Sarkar F., Wilke C., Glover T.W., Vaitkevicius V.K., Smith D.I. Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors. Cancer Res. 56:1996;4347-4350.
29. Lail A., Cussenoy O., Fournier G., Baron J.C., Lidereau R. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer. Cancer Res. 55:1997;1058-1062.
30. Zenkulsen J., Thompson J., Klein-Szanto A., Conti C. C-A)n microsatellite D7S522 is the most commonly deleted region in human primary breast cancer. Proc Natl Acad Sci USA. 91:1994;12155-12158.
31. Zenkulsen J., Weitzel J., Ball H., Conti C. Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene. Oncogene. 11:1995;359-363.
32. Berger R., Bloomfield C.D., Sutherland G.R. Human gene mapping 8. report on the committee on chromosome rearrangements in neoplasia and on fragile sites Cytogenet Cell Genet. 40:1983;490-535.
33. Yunis J.J., Hoffman W.R. Nuclear enzymes, fragile sites and cancer. J Gerentol. 44:1989;37-44.
34. Nakazawa Y., Chiba K., Imatoh N., Kotorii T., Sakamoto T., Ishazaki T. Serum folic acid levels and antipyrine clearance rates in smokers and non-smokers. Drug Alcohol Depend. 11:1983;201-207.